Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xiamen Amoytop Biotech CoSHSE:688278 +0.79%76 Days Inventory is 458.62 as of Mar. 2026, which is 34% above its 10-year median of 342.90. GuruFocus rates SHSE:688278 with a GF Score™ of 76/100 and a GF Value™ of ¥107.23 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 638 Biotechnology companies, Xiamen Amoytop Biotech Co ranks worse than 80.41% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Xiamen Amoytop Biotech Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.20.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Xiamen Amoytop Biotech Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.53.
Xiamen Amoytop Biotech Co (SHSE:688278) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Xiamen Amoytop Biotech Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Xiamen Amoytop Biotech Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Xiamen Amoytop Biotech Co Days Inventory Related Terms
Xiamen Amoytop Biotech Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688278 vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Xiamen Amoytop Biotech Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xiamen Amoytop Biotech Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xiamen Amoytop Biotech Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Xiamen Amoytop Biotech Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xiamen Amoytop Biotech Co (SHSE:688278) has a Days Inventory of 458.62 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Xiamen Amoytop Biotech Co and its competitors. This is 34% above median its historical median of 342.90. Over the past decade, Xiamen Amoytop Biotech Co's Days Inventory has ranged from 265.51 to 476.24. According to the industry distribution chart, Xiamen Amoytop Biotech Co ranks #513 out of 638 companies in the Biotechnology industry, placing it in the top 80.4%.
Is Xiamen Amoytop Biotech Co's Days Inventory too high?
Xiamen Amoytop Biotech Co's current Days Inventory of 458.62 is 34% above median its 10-year median of 342.90. Over the past 10 years, this metric has ranged from a low of 265.51 to a high of 476.24. The Biotechnology industry median Days Inventory is 182.60. Xiamen Amoytop Biotech Co's value of 458.62 is 151.2% above this industry median. Based on the distribution chart, Xiamen Amoytop Biotech Co ranks #513 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Xiamen Amoytop Biotech Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xiamen Amoytop Biotech Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Xiamen Amoytop Biotech Co ranks #513 out of 638 companies for Days Inventory. This places Xiamen Amoytop Biotech Co in the lower half of its industry. The industry median Days Inventory is 182.60. Xiamen Amoytop Biotech Co's value of 458.62 is 151.2% above this benchmark. Historically, Xiamen Amoytop Biotech Co's own Days Inventory has ranged from 265.51 to 476.24 over the past decade. While the company's 10-year median is 342.90 vs. the industry median of 182.60, Xiamen Amoytop Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 182.60, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xiamen Amoytop Biotech Co's current Days Inventory of 458.62 is 151.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Xiamen Amoytop Biotech Co and its competitors. For the Biotechnology industry, the median Days Inventory is 182.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xiamen Amoytop Biotech Co's current Days Inventory is 458.62, which is 34% above median its own 10-year median of 342.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiamen Amoytop Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co (SHSE:688278) is currently considered Possible Value Trap. The stock's GF Value™ is ¥107.23, compared to a current price of ¥58.35 — trading 45.6% below its estimated fair value. The current Days Inventory is 458.62, which is 34% above median its 10-year median of 342.90 and 151.2% above the Biotechnology industry median of 182.60. Xiamen Amoytop Biotech Co's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Xiamen Amoytop Biotech Co (SHSE:688278), the current Days Inventory is 458.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xiamen Amoytop Biotech Co (SHSE:688278) Overvalued in 2026?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co stock appears to be undervalued.
The current stock price of ¥58.35 is trading 45.6% below its estimated GF Value™ of ¥107.23.
GuruFocus considers Xiamen Amoytop Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688278:
Days Inventory: 458.62 (34% above median its 10-year median of 342.90)
GF Value™: ¥107.23 vs. price of ¥58.35 (45.6% below fair value)
Industry Position: 151.2% above the Biotechnology median (#513 of 638)
No single metric tells the full story. See the SHSE:688278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
76GF Score
Get the complete analysis for SHSE:688278
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688278 has been successfully added to your 
